CLARENDON HOUSE, 2 CHURCH STREET, HAMILTON HM11, D0
Market cap: $15.6B (12/18/2025)
Price: $22.41
Investor Presentation
Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Shareholder votes
Brepocitinib VALOR Phase 3 Study in DM on Track for 2025 Data Readout; Investor Event Highlights
Annual Report to Security Holders
News
Q2
Q1
FY 2024
Q3
S-3ASR
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Notice of Proposed Sale of Securities